These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23224239)

  • 1. Sub-toxic dose of apigenin sensitizes HepG2 cells to TRAIL through ERK-dependent up-regulation of TRAIL receptor DR5.
    Kim EY; Yu JS; Yang M; Kim AK
    Mol Cells; 2013 Jan; 35(1):32-40. PubMed ID: 23224239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.
    Sung B; Ravindran J; Prasad S; Pandey MK; Aggarwal BB
    J Biol Chem; 2010 Nov; 285(46):35418-27. PubMed ID: 20837473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galbanic acid potentiates TRAIL induced apoptosis in resistant non-small cell lung cancer cells via inhibition of MDR1 and activation of caspases and DR5.
    Kim YH; Shin EA; Jung JH; Park JE; Koo J; Koo JI; Shim BS; Kim SH
    Eur J Pharmacol; 2019 Mar; 847():91-96. PubMed ID: 30689998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thioridazine Sensitizes Apoptotic Effect of TRAIL in Human Lung Cancer PC9 Cells Through ER Stress Mediated Up-regulation of DR5].
    Li J; Wang Y; Liu L; Yuan Y; Bao Y
    Zhongguo Fei Ai Za Zhi; 2017 Feb; 20(2):80-87. PubMed ID: 28228218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic apoptosis of human gastric cancer cells by bortezomib and TRAIL.
    Bui HTT; Le NH; Le QA; Kim SE; Lee S; Kang D
    Int J Med Sci; 2019; 16(11):1412-1423. PubMed ID: 31673231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
    Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS
    Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celastrol enhances TRAIL-induced apoptosis in human glioblastoma via the death receptor pathway.
    Cha Z; Cheng J; Xiang H; Qin J; He Y; Peng Z; Jia J; Yu H
    Cancer Chemother Pharmacol; 2019 Oct; 84(4):719-728. PubMed ID: 31281953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camptothecin sensitizes human hepatoma Hep3B cells to TRAIL-mediated apoptosis via ROS-dependent death receptor 5 upregulation with the involvement of MAPKs.
    Jayasooriya RG; Choi YH; Hyun JW; Kim GY
    Environ Toxicol Pharmacol; 2014 Nov; 38(3):959-67. PubMed ID: 25461556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer.
    Yang J; Li G; Zhang K
    Biomed Pharmacother; 2016 Dec; 84():1078-1087. PubMed ID: 27780136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of p38 MAPK by damnacanthal mediates apoptosis in SKHep 1 cells through the DR5/TRAIL and TNFR1/TNF-α and p53 pathways.
    Lin FL; Hsu JL; Chou CH; Wu WJ; Chang CI; Liu HJ
    Eur J Pharmacol; 2011 Jan; 650(1):120-9. PubMed ID: 20951126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auriculasin sensitizes primary prostate cancer cells to TRAIL-mediated apoptosis through up-regulation of the DR5-dependent pathway.
    Cho HD; Gu IA; Won YS; Moon KD; Park KH; Seo KI
    Food Chem Toxicol; 2019 Apr; 126():223-232. PubMed ID: 30817944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apigenin sensitizes prostate cancer cells to Apo2L/TRAIL by targeting adenine nucleotide translocase-2.
    Oishi M; Iizumi Y; Taniguchi T; Goi W; Miki T; Sakai T
    PLoS One; 2013; 8(2):e55922. PubMed ID: 23431365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apigenin promotes TRAIL-mediated apoptosis regardless of ROS generation.
    Kang CH; Molagoda IMN; Choi YH; Park C; Moon DO; Kim GY
    Food Chem Toxicol; 2018 Jan; 111():623-630. PubMed ID: 29247770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin-mediated c-myc overexpression and cytochrome c (cyt c) release result in the up-regulation of the death receptors DR4 and DR5 and the activation of caspase 3 and caspase 9, likely responsible for the TRAIL-sensitizing effect of cisplatin.
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Med Oncol; 2015 Apr; 32(4):133. PubMed ID: 25796504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
    Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis.
    Nakata S; Yoshida T; Shiraishi T; Horinaka M; Kouhara J; Wakada M; Sakai T
    Mol Cancer Ther; 2006 Jul; 5(7):1827-35. PubMed ID: 16891469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
    Chang CC; Kuan CP; Lin JY; Lai JS; Ho TF
    Chem Res Toxicol; 2015 Aug; 28(8):1574-83. PubMed ID: 26203587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation.
    Chen L; Meng Y; Sun Q; Zhang Z; Guo X; Sheng X; Tai G; Cheng H; Zhou Y
    Cell Death Dis; 2016 Aug; 7(8):e2334. PubMed ID: 27512955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner.
    Chen M; Wang X; Zha D; Cai F; Zhang W; He Y; Huang Q; Zhuang H; Hua ZC
    Sci Rep; 2016 Oct; 6():35468. PubMed ID: 27752089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose 5-fluorouracil sensitizes HepG2 cells to TRAIL through TRAIL receptor DR5 and survivin-dependent mechanisms.
    Yang L; Wang Y; Zheng H; Zhang D; Wu X; Sun G; Yang T
    J Chemother; 2017 Jun; 29(3):179-188. PubMed ID: 28067150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.